What options did Matthew Paul Larson exercise related to SLDE shares?

Larson exercised stock options for 5,000 SLDE common shares at an exercise price of $0.79 per share. The filing notes these stock options are fully vested and exercisable, indicating they were already eligible to be converted into common stock.

Slide Insurance CRO exercises options, sells 5,000 shares

Q: What did SLDE Chief Risk Officer Matthew Paul Larson do in this Form 4?

Matthew Paul Larson exercised options for 5,000 SLDE shares at $0.79 and sold 5,000 shares in an open-market transaction. These coordinated transactions reflect an option exercise-and-sell pattern executed under a Rule 10b5-1 trading plan.

Q: At what prices were Matthew Paul Larson’s SLDE shares sold?

Larson’s 5,000 SLDE shares were sold at a weighted average price of $18.57 per share. According to the filing, individual sale prices ranged from $18.30 to $19.01 per share, all as part of the same open-market sale.

Q: What SLDE stock option holdings remain after Matthew Paul Larson’s transactions?

After the reported transactions, Larson’s Stock Option (Right to Buy) position shows 50,248 options outstanding. These options relate to SLDE common stock, are fully vested and exercisable, and are scheduled to expire on February 24, 2032.

Q: How many SLDE shares did Matthew Paul Larson sell in this Form 4?

The filing reports that Larson sold 5,000 shares of SLDE common stock in an open-market transaction. The transaction code is “S,” indicating a sale, and it was paired with an option exercise creating those same 5,000 shares.

Slide Insurance Holdings, Inc. Chief Risk Officer Matthew Paul Larson executed a pre-planned option exercise and share sale in SLDE stock.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Slide Insurance Holdings, Inc. Chief Risk Officer Matthew Paul Larson executed a pre-planned option exercise and share sale in SLDE stock. On May 4, 2026, he exercised stock options to acquire 5,000 shares of Common Stock at $0.79 per share and sold 5,000 shares in an open-market transaction at a weighted average price of $18.57 per share, with individual sale prices ranging from $18.30 to $19.01, under a Rule 10b5-1 trading plan adopted on December 4, 2025. Following the derivative transaction, his Stock Option (Right to Buy) position totaled 50,248 options that are fully vested and exercisable and are scheduled to expire on February 24, 2032.

Insider Trade Summary 10b5-1

Exercise and Sale: 5,000 shares ($89K approx. pre-tax spread)

Exercise and Sale 3 txns

Insider LARSON MATTHEW PAUL

Role Chief Risk Officer

Sold 5,000 shs ($93K)

Approx. gross sale proceeds $93K

Approx. exercise cost $4K

Approx. pre-tax spread $89K

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy)	5,000	$0.00	$0.00
Exercise	Common Stock	5,000	$0.79	$4K
Sale	Common Stock	5,000	$18.57	$93K

Holdings After Transaction: Stock Option (Right to Buy) — 50,248 contracts (Direct); Common Stock — 0 shares (Direct)

Footnotes (3)

F1. Exercised and sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 4, 2025.
F2. Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranges from $18.30 to $19.01 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
F3. These stock options are fully vested and exercisable.

Key Figures

Shares sold: 5,000 shares Weighted average sale price: $18.57 per share Options exercised: 5,000 shares +3 more

6 metrics

Shares sold 5,000 shares Open-market sale of common stock on May 4, 2026

Weighted average sale price $18.57 per share Sale of 5,000 SLDE shares, prices from $18.30 to $19.01

Options exercised 5,000 shares Stock option exercise to acquire common stock on May 4, 2026

Option exercise price $0.79 per share Conversion of Stock Option (Right to Buy) into common shares

Options outstanding after transaction 50,248 options Stock Option (Right to Buy) position following the exercise

Option expiration date February 24, 2032 Expiry for Stock Option (Right to Buy) linked to SLDE common stock

Key Terms

Rule 10b5-1 trading plan, Stock Option (Right to Buy), weighted average price, fully vested and exercisable, +1 more

5 terms

Rule 10b5-1 trading plan regulatory

"Exercised and sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

Stock Option (Right to Buy) financial

"security_title: "Stock Option (Right to Buy)" with underlying Common Stock"

weighted average price financial

"Represents the weighted average price of the shares sold"

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

fully vested and exercisable financial

"These stock options are fully vested and exercisable"

open-market sale financial

"transaction_action: "open-market sale" for 5,000 shares of Common Stock"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did SLDE Chief Risk Officer Matthew Paul Larson do in this Form 4?

Matthew Paul Larson exercised options for 5,000 SLDE shares at $0.79 and sold 5,000 shares in an open-market transaction. These coordinated transactions reflect an option exercise-and-sell pattern executed under a Rule 10b5-1 trading plan.

At what prices were Matthew Paul Larson’s SLDE shares sold?

Larson’s 5,000 SLDE shares were sold at a weighted average price of $18.57 per share. According to the filing, individual sale prices ranged from $18.30 to $19.01 per share, all as part of the same open-market sale.

Were Matthew Paul Larson’s SLDE transactions pre-planned under Rule 10b5-1?

Yes. The filing states the exercise and sale were completed under a Rule 10b5-1 trading plan adopted on December 4, 2025. Such plans allow insiders to schedule trades in advance, reducing the importance of short-term market timing.

What SLDE stock option holdings remain after Matthew Paul Larson’s transactions?

After the reported transactions, Larson’s Stock Option (Right to Buy) position shows 50,248 options outstanding. These options relate to SLDE common stock, are fully vested and exercisable, and are scheduled to expire on February 24, 2032.

How many SLDE shares did Matthew Paul Larson sell in this Form 4?

The filing reports that Larson sold 5,000 shares of SLDE common stock in an open-market transaction. The transaction code is “S,” indicating a sale, and it was paired with an option exercise creating those same 5,000 shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 05/06/2026 - 04:02 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

LARSON MATTHEW PAUL

(Last)

(First)

(Middle)

4221 W BOY SCOUT BLVD

SUITE 200

(Street)

TAMPA

FLORIDA

33607

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Slide Insurance Holdings, Inc. [ SLDE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Risk Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/04/2026		M		5,000	A	$0.79	5,000	D
Common Stock	05/04/2026		S		5,000⁽¹⁾	D	$18.57⁽²⁾	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (Right to Buy)	$0.79	05/04/2026		M⁽¹⁾			5,000	⁽³⁾	02/24/2032	Common Stock	5,000	$0	50,248	D

Explanation of Responses:

1. Exercised and sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 4, 2025.

2. Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranges from $18.30 to $19.01 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.

3. These stock options are fully vested and exercisable.

	/s/ Anastasios Omiridis, Attorney-in-Fact for Matthew Larson	05/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR